NCT06700876 Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
| NCT ID | NCT06700876 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mahidol University |
| Condition | Tuberculosis (TB) |
| Study Type | OBSERVATIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-08-06 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 160 participants in total. It began in 2024-08-06 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an observational study among approximately 160 end-stage renal disease patients on renal replacement therapy and post-living donor or deceased donor kidney transplant recipients. Investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB/RIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.
Eligibility Criteria
Inclusion Criteria: 1. End-stage renal disease on renal replacement therapy (hemodialysis or peritoneal dialysis) or status-post-living donor or deceased donor kidney transplantation 2. Aged more than or equal 18 years Exclusion Criteria: 1. Positive PPD test or a previously documented positive PPD 2. Active pulmonary or extrapulmonary tuberculosis
Contact & Investigator
Punnee Pitisuttithum, Prof. E.
STUDY CHAIR
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University
Frequently Asked Questions
Who can join the NCT06700876 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tuberculosis (TB). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06700876 currently recruiting?
Yes, NCT06700876 is actively recruiting participants. Contact the research team at Tanaya.sir@mahidol.edu for enrollment information.
Where is the NCT06700876 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT06700876 clinical trial?
NCT06700876 is sponsored by Mahidol University. The principal investigator is Punnee Pitisuttithum, Prof. E. at Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University. The trial plans to enroll 160 participants.